XRP surged 40% in two weeks while a growing share of its futures trading rotated onto CME Group’s regulated U.S. exchange, a shift that suggests professional money is entering the trade even as retail leverage drops off.
Outstanding XRP futures open interest across all exchanges fell 16% between Aug. 17 and Aug. 31, declining to about 2.34 billion tokens from 2.77 billion, according to CoinGlass data. XRP’s price climbed from roughly $0.99 to $1.38 over the same period, meaning traders were closing leveraged positions even as the token rallied strongly.
CME bucked that trend entirely. Open interest on the regulated exchange rose 36% to about 387 million tokens from 284 million, according to Commodity Futures Trading Commission data filed through Aug. 25. CME’s share of total outstanding XRP futures exposure jumped to roughly 17% from 10% in mid-August.
The result is a market where speculative leverage is falling but institutional positioning is rising, and both trends are happening at the same time. It is a rare configuration that points to a meaningful shift in who is driving the XRP trade and how they are accessing it.
Leveraged funds cut while dealers go long
The rotation reveals a clear split in how different categories of traders positioned during the rally. CFTC data through Aug. 25 show leveraged funds holding 892 long contracts against 3,206 shorts, leaving the group net short by about 116 million XRP. That figure more than doubled from roughly 57 million the week before.
Dealers and asset managers moved the opposite direction. Dealers added nearly 60 million XRP in net-long exposure, while asset managers added about 28 million. The CFTC report groups traders into categories but does not identify individual firms, so the 116 million XRP figure should not be read as a simple bearish wager against the token.
A hedge fund that holds a large spot XRP position might short futures to lock in gains, which would appear as a net-short position in the CFTC data even though the fund is long on the asset overall. The data shows positioning, not conviction.
The broader pattern is unusual. Traders typically move toward regulated venues when they are defensive and want the protections of a U.S. exchange. This time the rotation happened while the price was up almost 40% in two weeks, which suggests the institutional move is driven by portfolio building rather than risk reduction.
CLARITY Act vote looms in mid-September
The shift comes ahead of a Senate procedural vote on the CLARITY Act expected around September 15. The crypto market-structure bill has moved XRP repeatedly this year. The token jumped about 5% when the bill cleared the Senate Banking Committee in May, and traders are watching the upcoming vote as the next potential catalyst.
The CLARITY Act would divide regulatory responsibility between the Securities and Exchange Commission and the CFTC for digital assets. Under the current framework, it is unclear whether many tokens qualify as securities or commodities, creating legal uncertainty that has pushed institutional capital toward the sidelines for years.
A September 15 procedural vote is the next test for whether the bill moves toward full Senate debate. The bill needs 60 votes to advance, and unresolved disputes over stablecoin yield provisions and ethics requirements could complicate passage. The outcome will shape not just XRP but the broader derivatives market for crypto assets.
XRP’s August rally was its strongest monthly performance since early 2021, with most gains arriving in the final two weeks. ETF buying was a major driver, as institutional demand for XRP exchange-traded products accelerated through the summer. Polymarket currently prices the odds of XRP hitting an all-time high by September 30 at just 1.7%, rising to 8% by year end.
Institutional rotation, not retail speculation
The CME rotation matters because many institutional investors are required by mandate or preference to trade through regulated U.S. venues rather than offshore crypto exchanges. A rising CME share is one of the few observable signals that professional allocators are building positions rather than day-trading on leverage.
Bitcoin futures on CME have long held a dominant institutional share, often exceeding 25% of total open interest. XRP reaching similar status is newer and reflects the token’s improved regulatory standing after the SEC’s partial legal retreat earlier this year.
The shift also coincides with growing demand for XRP exchange-traded products. Goldman Sachs, Jane Street, and Millennium were among the largest holders in Q2 ETF filings, adding to the case that XRP’s investor base is broadening well beyond crypto-native traders and retail speculators.
CME now accounts for roughly 17% of all outstanding XRP futures. Two weeks ago it was 10%. That kind of shift in a short window is hard to explain without pointing to a specific cohort of money managers who either cannot or prefer not to use offshore venues like Binance and OKX.
September could test the rotation
The question is whether this rotation continues through September or stalls if the CLARITY Act fails to advance. XRP has historically sold off after regulatory disappointments, and a failed Senate vote could unwind both the price gains and the institutional positioning that came with them.
The Senate procedural vote is expected around September 15. If the bill clears, XRP could test $1.50 and CME’s share may keep climbing as more institutional mandates rotate onshore. If it fails, the leveraged funds that went net short may be proven right after all, and the CME rotation could reverse just as quickly as it started.
discussion